XT25XE5
Monitoring Kidney to New Technology Group 5 with Fluorescent Pyrazine, External Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | T Urinary System |
| Operation | 2 Monitoring |
| Body Part | 5 Kidney |
| Approach | X External |
| Device | E Fluorescent Pyrazine |
| Qualifier | 5 New Technology Group 5 |
Operation Definition
Determining the level of a physiological or physical function repetitively over a period of time
Procedure Overview
This family describes ongoing monitoring of a urinary system function using a newly approved technology, rather than a one-time test or a therapeutic procedure. It is used when a device tracks something like bladder pressure, flow, or another physiological parameter over a stretch of time rather than capturing a single reading, which lets clinicians see patterns that a single office visit would miss.
Patients who undergo this are often being followed for conditions such as neurogenic bladder, recurrent obstruction, or post-surgical recovery where continuous data helps guide decisions about medication or further intervention.
Anatomy & Axis Detail
Kidney
The kidney is a paired retroperitoneal organ responsible for filtering blood, regulating fluid and electrolyte balance, and producing urine, and it is a common site for physiologic monitoring in patients at risk for acute kidney injury or graft dysfunction. Monitoring under New Technology typically involves an implanted or applied sensor system that continuously tracks a physiological parameter, such as renal blood flow or oxygenation, rather than performing a single diagnostic test. This approach is distinct from imaging or laboratory assessment because it captures data over time, which can inform early intervention in critically ill or transplant patients. Because the kidney's function is closely tied to perfusion and hemodynamic status, the specific technology used for monitoring reflects emerging efforts to detect subclinical deterioration before overt organ failure develops.
Approach: External
External approach in New Technology applies to procedures performed directly on the skin, mucous membranes, or via direct visualization without penetrating a body cavity, such as applying or activating a device against the body surface. It contrasts with Percutaneous approaches, which require instrument entry through the skin rather than surface-level contact.
Device / Substance / Technology: Fluorescent Pyrazine
Fluorescent pyrazine is an intraoperative imaging agent administered to enable real-time fluorescence visualization of specific anatomic structures, such as the ureters, during surgery, helping surgeons avoid inadvertent injury. It functions differently from radiopaque contrast agents used in imaging studies, instead requiring a fluorescence-capable light source and camera system in the operating room. It is distinguished from monoclonal antibody or therapeutic substances by its purely visualization-based purpose.
Qualifier: New Technology Group 5
Group 5 designates technologies recognized under the New Technology section for the 2018-2019 update, sitting in the middle of the section's early expansion years. The qualifier's only job is to timestamp the code to its approval cohort; the actual clinical substance is defined by the other axis positions in the same code. Confusion most often arises with the neighboring Group 4 and Group 6 values, which cover adjacent years.
Coding & Documentation
For this code family, the documentation needs to show that a specific new-technology monitoring device or system was used, and that it collected data over a defined period rather than at a single moment. The clinical note should identify the device by name and describe what was being measured.
A frequent coding mistake is applying a monitoring code to what was actually a single diagnostic measurement, such as a one-time urodynamic study, which belongs under a different root operation entirely. Coders should also confirm that the device qualifies under the New Technology pathway rather than an established monitoring approach already covered elsewhere in the coding system.
Commonly Confused With
This is often confused with Measurement procedures found elsewhere in the coding system, which capture a single value at one point in time. Monitoring specifically implies repeated or continuous data collection, so the deciding factor is whether the record describes an ongoing tracking period or a single test result.